Large interindividual variability in peritoneal solute transfer, determined by the peritoneal equilibration test (PET) at the start of peritoneal dialysis (PD) therapy, has been previously shown (1,2). The contributing factors are not well defined, but may include differences in age, peritoneal surface area, peritoneal permeability, or peritoneal blood flow. The structural or functional changes in peritoneal vasculature produced by systemic atherosclerosis may influence peritoneal solute transport properties. In this study, we quantified the degree of systemic atherosclerosis and investigated its correlation with solute transport in the early phase of PD therapy.
Get full access to this article
View all access options for this article.
References
1.
LoW.K., BrendolanA., ProwantB.F., MooreH.L., KhannaR., TwardowskiZ.J.Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients.J Am Soc Nephrol1994; 4: 1466–74.
2.
DaviesS.J., BrownB., BryanJ., RussellG.I.Clinical evaluation of the peritoneal equilibration test. A population based study.Nephrol Dial Transplant1993; 8: 64–70.
